Eglucent Mix 25 Kwikpen

Composition

Insulin lispro protamine suspension 25% + Insulin lispro 75% (100 IU/mL)

Uses of Eglucent Mix 25 Kwikpen

Treatment of diabetes mellitus (type 1 and type 2) to improve blood glucose control when a premixed rapid-acting insulin regimen is indicated

• •Controls post‑meal and between‑meal blood glucose
• •Convenient premixed insulin option
• •Helps reduce HbA1c with regular use
• •Pen device enables accurate dosing and easier administration

How it works

This is a premixed insulin analogue containing rapid-acting insulin lispro and intermediate-acting insulin lispro protamine. The lispro component covers post‑meal blood sugar spikes, while the protamine component provides longer basal coverage between meals and overnight.

Directions for use

For subcutaneous injection using the prefilled 3 mL KwikPen as prescribed by the doctor. Typically injected within 15 minutes before a meal or immediately after a meal; dose and timing depend on blood glucose, diet and activity. Gently roll/rotate the pen to resuspend until uniformly cloudy before use; do not use if clumped or not uniformly mixed. Rotate injection sites (abdomen, thigh, upper arm, buttock); do not inject into a vein or muscle. Use a new needle each time and do not share the pen.

Side effects

Common side effects of Eglucent Mix 25 Kwikpen may include:

• •Hypoglycaemia (low blood sugar)
• •injection site reactions (pain
• •